These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 17304447

  • 21. The benefit of empiric treatment for methicillin-resistant Staphylococcus aureus.
    Chuck EA, Frazee BW, Lambert L, McCabe R.
    J Emerg Med; 2010 Jun; 38(5):567-71. PubMed ID: 18514468
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
    Arnold FW, Wojda B.
    J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
    [Abstract] [Full Text] [Related]

  • 25. Emergence of community-acquired methicillin-resistant Staphylococcus aureus soft tissue infections.
    Olesevich M, Kennedy A.
    J Pediatr Surg; 2007 May; 42(5):765-8. PubMed ID: 17502179
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)--a new challenge in the ambulatory setting?].
    Buehlmann M, Chuard C.
    Rev Med Suisse; 2007 Oct 10; 3(128):2289-90, 2292-3. PubMed ID: 17985605
    [Abstract] [Full Text] [Related]

  • 28. Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Ruhe JJ, Menon A.
    Antimicrob Agents Chemother; 2007 Sep 10; 51(9):3298-303. PubMed ID: 17576834
    [Abstract] [Full Text] [Related]

  • 29. Geographic distribution of community-acquired methicillin-resistant Staphylococcus aureus soft tissue infections.
    Rossini CJ, Moriarty KP, Tashjian DB, Garb JL, Wait RB.
    J Pediatr Surg; 2011 Jun 10; 46(6):1089-92. PubMed ID: 21683204
    [Abstract] [Full Text] [Related]

  • 30. Antibiotic options for treating community-acquired MRSA.
    Powell JP, Wenzel RP.
    Expert Rev Anti Infect Ther; 2008 Jun 10; 6(3):299-307. PubMed ID: 18588495
    [Abstract] [Full Text] [Related]

  • 31. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Sharpe JN, Shively EH, Polk HC.
    Am J Surg; 2005 Apr 10; 189(4):425-8. PubMed ID: 15820454
    [Abstract] [Full Text] [Related]

  • 32. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: report of a local outbreak and implications for emergency department care.
    Fleming SW, Brown LH, Tice SE.
    J Am Acad Nurse Pract; 2006 Jun 10; 18(6):297-300. PubMed ID: 16719849
    [Abstract] [Full Text] [Related]

  • 33. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ, Nix DE, Armstrong EP.
    Ann Pharmacother; 2004 Sep 10; 38(9):1377-82. PubMed ID: 15266044
    [Abstract] [Full Text] [Related]

  • 34. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature.
    Khawcharoenporn T, Alan T.
    Hawaii Med J; 2006 Oct 10; 65(10):290-3. PubMed ID: 17194061
    [Abstract] [Full Text] [Related]

  • 35. Should the methicillin-resistant Staphylococcus aureus carriage status be used as a guide to treatment for skin and soft tissue infections?
    Reber A, Moldovan A, Dunkel N, Emonet S, Rohner P, Tahintzi P, Hoffmeyer P, Harbarth S, Uçkay I.
    J Infect; 2012 May 10; 64(5):513-9. PubMed ID: 22327191
    [Abstract] [Full Text] [Related]

  • 36. [Community MRSA].
    Witte W, Mielke M.
    Zentralbl Chir; 2007 Apr 10; 132(2):124-9. PubMed ID: 17516318
    [Abstract] [Full Text] [Related]

  • 37. Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Popovich KJ, Hota B.
    Dermatol Ther; 2008 Apr 10; 21(3):167-79. PubMed ID: 18564247
    [Abstract] [Full Text] [Related]

  • 38. Perirectal abscess infections related to MRSA: a prevalent and underrecognized pathogen.
    Brown SR, Horton JD, Davis KG.
    J Surg Educ; 2009 Apr 10; 66(5):264-6. PubMed ID: 20005498
    [Abstract] [Full Text] [Related]

  • 39. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
    Szumowski JD, Cohen DE, Kanaya F, Mayer KH.
    Antimicrob Agents Chemother; 2007 Feb 10; 51(2):423-8. PubMed ID: 17116664
    [Abstract] [Full Text] [Related]

  • 40. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients.
    Trinh TT, Short WR, Mermel LA.
    J Int Assoc Physicians AIDS Care (Chic); 2009 Feb 10; 8(3):176-80. PubMed ID: 19423878
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.